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ABSTRACT
Orexin-A (hypocretin-1), a neuropeptide, was originally shown to be specifi cally expressed in the 
hypothalamus. We studied the presence of orexin-A immunoreactivity in ostrich kidneys. Immunocytochemistry 
showed that orexin-A immunoreactivity was localized in the tubules of the ostrich kidneys. Immunoreactivity 
was found both in the renal cortex and the medulla. Immunostaining was mainly localized in the apical border 
and lumen of tubules. 
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Introduction
Orexins (hypocretins) are neuropeptides that were originally shown to be specifi cally 
expressed in the hypothalamus. Orexins consist of orexin A (OXA; hypocretin 1) and 
orexin B (OXB; hypocretin 2) which are 33- and 28-amino acid peptides originating 
from a single precursor, produced by prepro-orexin (PPO) gene (DE LECEA et al., 1998; 
SAKURAI et al., 1998). There are at least two types of orexin receptors: orexin receptors 1 
and 2, which are both G protein-coupled receptors and display different affi nities for the 
two orexin peptides. Orexin receptor 2 binds orexin-A and -B with the similar affi nities, 
whereas orexin receptor 1 is 30-100 times more responsive to orexin-A than orexin-B 
(SAKURAI et al., 1998).
 Orexins are thought to be involved in the control mechanisms for food intake 
(WILLIE et al., 2001), sleep (MONDA et al., 2003), thermoregulation and autonomic 
and cardiovascular functions (SHIRASAKA et al., 1999). Although orexins and their 
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functions have been mainly described in the central nervous system (CNS), there are 
substantial data implying that orexins may also function outside the CNS. Orexins and 
their receptors have been detected in a wide range of tissues, including the intestine, 
pancreas, adrenals, kidney, adipose tissue and reproductive tract in mammals (JOHREN 
et al., 2001; KIRCHGESSNER and LIU, 1999; NAKABAYASHI et al., 2003; SILVEYRA et al., 
2007a; SILVEYRA et al., 2007b). Also, in chickens OXR is cloned widely in the brain and 
abundant expression is observed in the cerebrum, hypothalamus (OHKUBO et al., 2003).
 Although the precise functions of orexins still remain unclear in many tissues, it 
has been reported that orexin A, but not orexin B, penetrates the blood-brain barrier by 
simple diffusion (KASTIN and AKERSTROM, 1999). Orexins also affect insulin release, 
intestinal motility and secretion (NOWAK et al., 2000). Furthermore, orexins have anti-
growth effects in cultured colon cancer and neuroblastoma cells (ROUET-BENZINEB et 
al., 2004). Orexin A-like immunoreactivity is present in human plasma (ARIHARA et al., 
2001) and plasma concentrations of orexinA-LI were elevated in patients with chronic 
renal failure (SUGIMOTO et al., 2002).
 In the kidneys, orexin receptor 1 has been found in the rat (JOHREN et al., 2001), and 
orexin receptor 1 and orexin receptor 2 mRNA in humans (NAKABAYASHI et al., 2003; 
TAKAHASHI et al., 2006). In addition to these reports, TAKAHASHI et al. (2006) reported 
localization of orexin A immunoreactivity in human kidney tubules.
Although orexins have been studied in some detail in mammal kidneys, no information 
is so far available about the occurrence and or distribution of orexins in the kidney of non-
mammals. Thus, in order to help completion of phylogenetic analysis in the expression of 
this neuropeptides in the kidney of vertebrates, the presence and localization of orexin A 
immunoreactivity are reported here in avian kidneys.
Materials and methods
Animals and tissue samples. Five adult male ostriches were used. Birds with a body 
mass of 45-60 kg were anaesthetized by injecting pentobarbitone sodium. The left carotid 
artery was cannulated at the base of the neck and allowed to exsanguinate. Tissue samples 
were immediately collected from the kidneys and fi xed in 4% neutral-buffered formalin 
for 24 h. They were then dehydrated through graded ethanol and embedded in paraffi n. 
Seven μm-thick sections were obtained and processed for immunohistochemical staining.
Immunohistochemistry. Immunohistochemical staining was carried out using the 
peroxidase-antiperoxidase (PAP) method. Blocking of endogenous peroxidase was carried 
out with 3% hydrogen peroxidase (H2O2) in methanol for 10 minutes (STERNBERGER, 
1979). In order to block unspecifi c binding, incubation with normal goat serum in 0.1 M 
phosphate buffered saline (PBS), pH 7.2 (Dilution 1:10) was performed. Sections were 
incubated for 16-20 hours at 4 oC with rabbit IgG antibodies against Orexin-A (Millipore, 
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AB3704). The primary antibodies were diluted to 1:3000 in PBS containing 0.25% 
sodium azide and 2.5% bovine serum albumin (BSA). Sections were then incubated 
in goat anti-rabbit IgG (Dako, Z0421, Denmark) followed by rabbit peroxidase anti-
peroxidase complex (Zymed Lab., 61.2003, San Francisco), both at a dilution of 1:50 
in PBS, for 1 hour at room temperature. Sections were washed in PBS for 30 minutes 
after each incubation and fi nally immersed in glucose oxidise-DAB-nickel ammonium 
sulphate substrate (SHU et al., 1988) for 10 minutes. After washing in distilled water and 
counterstaining with hematoxylin, sections were dehydrated and coverslips mounted with 
aqueous permanent mounting medium.
The controls for the specifi city of immunhistochemical reactions were performed by 
the pre-absorption of each antiserum with the corresponding antigen (STERNBERGER, 
1986). Sections were examined with an Olympus BX-51 microscope and photographs 
were taken. 
Results
Immunohistochemistry showed that orexin-A immunoreactivity was localized in the 
renal tubular cells of the ostrich kidneys. Immunoreactive tubules were localized both in 
the renal cortex (Fig. 1A) and the medulla (Fig. 1B). In the renal tubules, immunostaining 
was observed generally in the apical surface of the cells. Proximal convoluted tubules 
were showed more dense immunoreactivity, and staining was localized mainly in the 
microvillus and lumen (Fig. 1A). No positive immunostaining was found in the glomerulus 
or in the vasculature. 
The negative control using non-immune rabbit serum gave no positive immunostaining. 
Fig. 1. Orexin A immunoreactive tubules in the renal cortexs (Fig. 1A arrows) and medulla (Fig. 
1B arrows) of ostrich kidney. Positive immunoreactivity in the microvillus and lumen of proximal 
convoluted tubules (Fig. 1A arrows). Glomerulus (g) and vascularite (v) were not showed 
immunoreactivity (Fig. 1A and B).
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Discussion
Orexins and their receptors have been detected in a wide range of organs outside the 
CNS and several groups have demonstrated their involvement in a number of physiological 
processes (JOHREN et al., 2001; KIRCHGESSNER and LIU, 1999; NAKABAYASHI et al., 
2003; SILVEYRA et al., 2007a; SILVEYRA et al., 2007b). Orexins stimulate arousal and appetite 
in the brain (CHEMELLI et al., 1999; HAGAN et al., 1999; SAKURAI et al., 1998). Orexins may 
stimulate insulin secretion (NOWAK et al., 2000) and adrenocortical hormones (JOHREN et al., 
2004). 
On the other hand, the precise mechanism of the action of orexins has not been clarifi ed 
in the kidney. However, TAKAHASHİ et al. (2006) reported that orexin-A is produced by 
human kidneys, particularly the renal tubular cells and they raised the possibility that 
orexin-A may regulate tubular function and renal circulation as an autocrine or paracrine 
regulator. They also revealed that orexin-A is secreted to the urine by renal tubular cells, 
and they suggested that it may regulate renal reabsorbtion and secretion as an urocrine 
mediator.
In the present study, orexin-A immunoreactivity was examined and detected in the 
ostrich kidney. This is the fi rst report of the localization of orexin-A in the avian kidney. 
Immunocytochemistry showed that orexin-A immunoreactivity was localized in the 
tubules. Renal tubular cells were diffusely immunostained with orexin-A, both in the 
renal cortex and the medulla. No positive immunostaining was found in the glomerulus 
or in the vasculature. 
In conclusion, the results obtained indicated that there are no clear differences 
between the ostrich and human concerning the existence and localization of orexin-A in 
the kidney. Thus, we can suggest that orexin-A might be involved in a similar function in 
avian kidneys as reported in mammalian kidneys (TAKAHASHI et al., 2006). On the other 
hand, our results raised the possibility that orexin-A may regulate the tubular function in 
the kidney as an autocrine or paracrine mediator. Further study, however, is required to 
reveal the precise effects of orexin-A in avian kidneys.
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SAŽETAK
Neuropeptid oreksin-A (hypokretin-1) izvorno je bio dokazan u hipotalamusu. U ovom je radu njegova 
imunoreaktivnost istražena u bubregu noja. Imunohistokemijski je dokazana njegova imunoreaktivnost 
u bubrežnim tubulima. Dokazana je također u kori i srži bubrega. Aktivnost je pretežito bila lokalizirana u 
apikalnom području i lumenu bubrega.
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